One year in review 2020: novelties in the treatment of rheumatoid arthritis
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …
recommendations help in refining the relevant place of different disease-modifying anti …
Trajectories of biologic drug use before, during and after pregnancy: an Italian cohort study from the VALORE project
S Lopes, M Servadio, A Spini, L L'Abbate… - Expert Opinion on …, 2025 - Taylor & Francis
Background Monitoring biologic drug therapy during pregnancy in women with immune-
mediated inflammatory diseases (IMIDs) is crucial to ensure treatments align with evidence …
mediated inflammatory diseases (IMIDs) is crucial to ensure treatments align with evidence …
Azathioprine pretreatment ameliorates myocardial ischaemia reperfusion injury in diabetic rats by reducing oxidative stress, apoptosis, and inflammation
C Lu, L Liu, S Chen, J Niu, S Li, W Xie… - Clinical and …, 2021 - Wiley Online Library
This study was presented to observe the therapeutic effects of azathioprine (AZA)
pretreatment on myocardial ischaemia reperfusion (I/R) damage in diabetic rats. All rats …
pretreatment on myocardial ischaemia reperfusion (I/R) damage in diabetic rats. All rats …
[HTML][HTML] Bioinformatics analysis of ceRNA regulatory network of baicalin in alleviating pathological joint alterations in CIA rats
Y Yang, H Li, L Bai, S Yao, W Zhang, T Wang… - European Journal of …, 2023 - Elsevier
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation
of synovium, leading to cartilage damage, bone erosion, even joint destruction and …
of synovium, leading to cartilage damage, bone erosion, even joint destruction and …
Trends in medications for autoimmune disorders during pregnancy and factors for their discontinuation: a population-based study
Objectives The medications used for autoimmune diseases have significantly evolved in
recent years, but there is limited knowledge about how treatment practices changed during …
recent years, but there is limited knowledge about how treatment practices changed during …
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis
MC Gerardi, F Crisafulli, A García-Fernandez… - Frontiers in …, 2022 - frontiersin.org
Objectives: Women with Rheumatoid Arthritis (RA) can experience flares during pregnancy
that might influence pregnancy outcomes. We aimed at assessing the disease course during …
that might influence pregnancy outcomes. We aimed at assessing the disease course during …
Rheumatoid Arthritis and Pregnancy: Managing Disease Activity and Fertility Concerns
D Marcy, JA Zell, MK Demoruelle - Seminars in Reproductive …, 2024 - thieme-connect.com
Rheumatoid arthritis (RA) is a systemic autoimmune disease that more commonly affects
women, including many women during the childbearing years. This can make management …
women, including many women during the childbearing years. This can make management …
Patterns of immunosuppressive drug use during pregnancy in women with systemic vasculitis: A nationwide population-based cohort study
C Mettler, N Beeker, M Collier, V Le Guern… - European Journal of …, 2023 - Elsevier
Objective Systemic vasculitis (SV) rarely affects women of childbearing age and only small
series have been reported to date in pregnant patients. The discovery of an unplanned …
series have been reported to date in pregnant patients. The discovery of an unplanned …
Pre-pregnancy planning for female patients seen at a pregnancy and rheumatic diseases clinic: a retrospective analysis of patients with rheumatic diseases seeking …
To assess the clinical utility of pre-pregnancy planning among female patients with
rheumatic diseases attending a targeted pregnancy and rheumatic diseases clinic. We …
rheumatic diseases attending a targeted pregnancy and rheumatic diseases clinic. We …
Perinatal Use and Discontinuation of Disease-Modifying Antirheumatic Drugs: Outcomes of Patients Seen at a Pregnancy and Rheumatic Diseases Clinic
Background Managing rheumatic disease activity using pregnancy-compatible medications
is essential for reducing adverse maternal and fetal outcomes. We characterized medication …
is essential for reducing adverse maternal and fetal outcomes. We characterized medication …